Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $2.64 billion. The enterprise value is $2.37 billion.
| Market Cap | 2.64B |
| Enterprise Value | 2.37B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 535.42 million shares outstanding. The number of shares has increased by 6.87% in one year.
| Current Share Class | 439.71M |
| Shares Outstanding | 535.42M |
| Shares Change (YoY) | +6.87% |
| Shares Change (QoQ) | +2.21% |
| Owned by Insiders (%) | 21.52% |
| Owned by Institutions (%) | 27.95% |
| Float | 416.64M |
Valuation Ratios
The trailing PE ratio is 252.56 and the forward PE ratio is 64.72.
| PE Ratio | 252.56 |
| Forward PE | 64.72 |
| PS Ratio | 1.00 |
| Forward PS | 0.78 |
| PB Ratio | 6.58 |
| P/TBV Ratio | 7.10 |
| P/FCF Ratio | 20.80 |
| P/OCF Ratio | 20.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 190.20, with an EV/FCF ratio of 18.78.
| EV / Earnings | 199.52 |
| EV / Sales | 0.91 |
| EV / EBITDA | 190.20 |
| EV / EBIT | 199.50 |
| EV / FCF | 18.78 |
Financial Position
The company has a current ratio of 1.55, with zero debt.
| Current Ratio | 1.55 |
| Quick Ratio | 1.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.40% and return on invested capital (ROIC) is 2.13%.
| Return on Equity (ROE) | 3.40% |
| Return on Assets (ROA) | 1.19% |
| Return on Invested Capital (ROIC) | 2.13% |
| Return on Capital Employed (ROCE) | 3.05% |
| Weighted Average Cost of Capital (WACC) | 17.89% |
| Revenue Per Employee | $3.78M |
| Profits Per Employee | $17,196 |
| Employee Count | 724 |
| Asset Turnover | 4.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.21% in the last 52 weeks. The beta is 2.48, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | +85.21% |
| 50-Day Moving Average | 4.56 |
| 200-Day Moving Average | 3.60 |
| Relative Strength Index (RSI) | 58.90 |
| Average Volume (20 Days) | 4,416,068 |
Short Selling Information
The latest short interest is 25.95 million, so 4.85% of the outstanding shares have been sold short.
| Short Interest | 25.95M |
| Short Previous Month | 22.90M |
| Short % of Shares Out | 4.85% |
| Short % of Float | 6.23% |
| Short Ratio (days to cover) | 5.73 |
Income Statement
In the last 12 months, CLOV had revenue of $2.74 billion and earned $12.45 million in profits. Earnings per share was $0.02.
| Revenue | 2.74B |
| Gross Profit | 516.60M |
| Operating Income | 12.45M |
| Pretax Income | 12.45M |
| Net Income | 12.45M |
| EBITDA | 13.06M |
| EBIT | 12.45M |
| Earnings Per Share (EPS) | $0.02 |
Balance Sheet
The company has $332.74 million in cash and no debt, with a net cash position of $268.07 million or $0.50 per share.
| Cash & Cash Equivalents | 332.74M |
| Total Debt | n/a |
| Net Cash | 268.07M |
| Net Cash Per Share | $0.50 |
| Equity (Book Value) | 390.87M |
| Book Value Per Share | 0.73 |
| Working Capital | 189.16M |
Cash Flow
In the last 12 months, operating cash flow was $135.31 million and capital expenditures -$3.03 million, giving a free cash flow of $132.28 million.
| Operating Cash Flow | 135.31M |
| Capital Expenditures | -3.03M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 132.28M |
| FCF Per Share | $0.25 |
Margins
Gross margin is 18.86%, with operating and profit margins of 0.45% and 0.45%.
| Gross Margin | 18.86% |
| Operating Margin | 0.45% |
| Pretax Margin | 0.45% |
| Profit Margin | 0.45% |
| EBITDA Margin | 0.48% |
| EBIT Margin | 0.45% |
| FCF Margin | 4.83% |
Dividends & Yields
CLOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.87% |
| Shareholder Yield | -6.87% |
| Earnings Yield | 0.40% |
| FCF Yield | 4.81% |
Analyst Forecast
The average price target for CLOV is $5.60, which is 13.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.60 |
| Price Target Difference | 13.71% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 30.53% |
| EPS Growth Forecast (3Y) | 83.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |